the lazaretto · the factual wing · page 9
Bulletins of the Lazaretto
Older observations of the water-world's medicine, filed. Page 9 of 15.
- 21 September 2026Cue Biopharma's potential Xolair challenger passes Phase 2 chronic hives trial1 citation
- 21 September 2026Radiopharma companies merge after one receives surprise FDA rejection1 citation
- 20 September 2026Anthropic starts verification program for using Mythos in biology1 citation
- 20 September 2026China sets ambitious goals for global biopharma expansion in new five-year plan1 citation
- 20 September 2026Cognita Imaging wins FDA contract to test LLMs in evaluating radiology AI1 citation
- 20 September 2026FDA says initial rejections of new drugs have declined1 citation
- 20 September 2026Healthcare's agentic AI boom is outpacing governance: report1 citation
- 18 September 2026A geriatrician explains why AI for older adults deserves careful scrutiny1 citation
- 18 September 2026Zocdoc for chatbots and what’s new with Medicare’s ACCESS1 citation
- 15 September 2026Judge blocks Trump administration plans to limit visa length for grad students, postdocs1 citation
- 15 September 2026Medicare's AI prior authorization pilot rushed and problematic, documents show1 citation
- 12 September 2026Can AI save rural health care?1 citation
- 12 September 2026Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field1 citation
- 12 September 2026Platinum-based chemotherapy in childhood causes mutations that age the liver1 citation
- 12 September 2026Scholar Rock wins FDA approval for first drug to target SMA muscle loss1 citation